Baraclude (entecavir), a new oral antiviral for chronic hepatitis B

Some patients will be getting Baraclude (entecavir), a new oral antiviral for chronic hepatitis B.

It will be used as an alternative to Intron A (interferon alfa-2b)...Epivir-HBV (lamivudine)... or Hepsera (adefovir).

Intron A is effective for suppressing the hepatitis B virus and requires a shorter treatment duration than the oral antivirals.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote